
                                SEQUENCE LISTING

<110> Hsu, Tracy
      Mitragotri, Samir M.

<120> Skin Permeating And Cell Entering
  (SPACE) Peptides and Methods of Use Thereof
  

<130> UCSB-532

<150> 61/411,884          
<151> 2010-11-09  

<150> 61/527,574          
<151> 2011-08-25  

<150> 61/528,036          
<151> 2011-08-26  

<160> 29

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 1
Thr Gly Ser Thr Gln His Gln
 1               5          


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display

<400> 2
His Ser Ala Leu Thr Lys His
 1               5          


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 3
Lys Thr Gly Ser His Asn Gln
 1               5          


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 4
Met Gly Pro Ser Ser Met Leu
 1               5          


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 5
Thr Asp Pro Asn Gln Leu Gln
 1               5          


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 6
Ser Thr His Phe Ile Asp Thr
 1               5          


<210> 7
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 7
Cys Thr Gly Ser Thr Gln His Gln Cys
 1               5                  


<210> 8
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 8
Cys His Ser Ala Leu Thr Lys His Cys
 1               5                  


<210> 9
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 9
Cys Lys Thr Gly Ser His Asn Gln Cys
 1               5                  


<210> 10
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 10
Cys Met Gly Pro Ser Ser Met Leu Cys
 1               5                  


<210> 11
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 11
Cys Thr Asp Pro Asn Gln Leu Gln Cys
 1               5                  


<210> 12
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 12
Cys Ser Thr His Phe Ile Asp Thr Cys
 1               5                  


<210> 13
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 13
Ala Cys Thr Gly Ser Thr Gln His Gln Cys Gly
 1               5                  10      


<210> 14
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 14
Ala Cys His Ser Ala Leu Thr Lys His Cys Gly
 1               5                  10      


<210> 15
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 15
Ala Cys Lys Thr Gly Ser His Asn Gln Cys Gly
 1               5                  10      


<210> 16
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display a

<400> 16
Ala Cys Met Gly Pro Ser Ser Met Leu Cys Gly
 1               5                  10      


<210> 17
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 17
Ala Cys Thr Asp Pro Asn Gln Leu Gln Cys Gly
 1               5                  10      


<210> 18
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> identified using phage display 

<400> 18
Ala Cys Ser Thr His Phe Ile Asp Thr Cys Gly
 1               5                  10      


<210> 19
<211> 6
<212> DNA
<213> Artifiicial Sequence

<220> 
<223> portion of artificial DNA sequence, specifically
      a vector restriction site.

<400> 19
cggccg                                                            6

<210> 20
<211> 6
<212> DNA
<213> Artificial Sequence

<220> 
<223> portion of artificial DNA sequence, specifically
     a vector restriction site.

<400> 20
ccgcgg                                                            6

<210> 21
<211> 39
<212> DNA
<213> Artificial Sequence

<220> 
<223> forward primer

<400> 21
gttccgcgga aactgttgaa agttgtttag caaaatccc                        39

<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> portion of a control peptide amino acid sequence

<400> 22
Thr His Gly Gln Thr Gln Ser
 1               5          


<210> 23
<211> 102
<212> DNA
<213> Artificial Sequence

<220> 
<223> reverse primer

<400> 23
tttccgcgga acctccaccg cactgatgct gctcgaacca gtacaagcag agtgagaata 60
gaaaggtact actaaaggaa ttgcgaataa taattttttc ac                    102

<210> 24
<211> 82
<212> DNA
<213> Artificial Sequence

<220> 
<223> reverse primer

<400> 24
tttccgcgga acctccaccg caacaagcag agtgagaata gaaaggtact actaaaggaa 60
ttgcgaataa taattttttc ac                                          82

<210> 25
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> control peptide amino acid sequence

<400> 25
Ala Cys Thr His Gly Gln Thr Gln Ser Cys Gly
 1               5                  10      


<210> 26
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> Green Fluorescent Protein (GFP) siRNA

<400> 26
gacguaaacg gccacaaguu c                                           21

<210> 27
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> Interleukin-10 (IL-10) siRNA sequence

<400> 27
gaaugaauuu gacaucuucu u                                           21

<210> 28
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> luciferase (control) siRNA sequence
      siRNA sequence

<400> 28
uaaggcuaug aagagauacu u                                           21

<210> 29
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
      siRNA sequence

<400> 29
gugugaacca cgagaaauau u                                           21
